Published in Cancer on November 12, 2012
Racial disparities in survival among patients with advanced renal cell carcinoma in the targeted therapy era. Cancer (2016) 2.00
Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics. Cancer (2013) 1.06
Racial difference in histologic subtype of renal cell carcinoma. Cancer Med (2013) 0.96
Differences in breast cancer characteristics and outcomes between Caucasian and Chinese women in the US. Oncotarget (2015) 0.86
Intrinsic Genomic Differences Between African American and White Patients With Clear Cell Renal Cell Carcinoma. JAMA Oncol (2016) 0.85
Sorafenib neoadjuvant therapy in the treatment of high risk renal cell carcinoma. PLoS One (2015) 0.80
Genetic variation in the GSTM3 promoter confer risk and prognosis of renal cell carcinoma by reducing gene expression. Br J Cancer (2013) 0.79
Survival among Black and White patients with renal cell carcinoma in an equal-access health care system. Cancer Causes Control (2015) 0.78
Racial disparities in overall survival among renal cell carcinoma patients with young age and small tumors. Cancer Med (2015) 0.77
A comparison of abdominal surgical outcomes between African-American and Caucasian Crohn's patients. Int J Colorectal Dis (2014) 0.77
Racial disparities in renal cell carcinoma: a single-payer healthcare experience. Cancer Med (2016) 0.75
Reply to 'Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics'. Cancer (2013) 0.75
Physical activity and renal cell carcinoma among black and white Americans: a case-control study. BMC Cancer (2014) 0.75
Genomic differences between black and white patients implicate a distinct immune response to papillary renal cell carcinoma. Oncotarget (2016) 0.75
Variable risk of second primary malignancy in multiple myeloma patients of different ethnic subgroups. Blood Cancer J (2014) 0.75
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA (2010) 13.94
The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr (1961) 10.35
Rising incidence of renal cell cancer in the United States. JAMA (1999) 9.57
Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48
Epidemiology and risk factors for kidney cancer. Nat Rev Urol (2010) 5.25
Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol (2003) 3.66
Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram. J Clin Oncol (2009) 3.38
Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol (2005) 3.15
Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. J Urol (2010) 3.06
Progression is accelerated from prehypertension to hypertension in blacks. Hypertension (2011) 2.82
Contemporary epidemiology of renal cell cancer. Cancer J (2008) 2.40
Racial/ethnic and gender disparities in renal cell carcinoma incidence and survival. J Urol (2008) 2.04
Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population. Eur Urol (2011) 1.87
National trends in the use of partial nephrectomy: a rising tide that has not lifted all boats. J Urol (2012) 1.84
Hypertension and risk of renal cell carcinoma among white and black Americans. Epidemiology (2011) 1.61
Disparities in treatment and outcome for renal cell cancer among older black and white patients. J Clin Oncol (2007) 1.56
Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma. Carcinogenesis (2010) 1.50
Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification. Urology (2007) 1.26
A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study. BJU Int (2008) 1.20
Racial disparity in outcomes of a clinical trial population with metastatic renal cell carcinoma. Urology (2006) 1.19
Race affects access to nephrectomy but not survival in renal cell carcinoma. BJU Int (2008) 0.98
Renal cancer paradox: higher incidence but not higher mortality among African-Americans. Eur J Cancer Prev (2011) 0.95
Characteristics and prognosis of chromophobe non-metastatic renal cell carcinoma: a multicenter study. Int J Urol (2010) 0.95
Rate of renal cell carcinoma subtypes in different races. Int Braz J Urol (2011) 0.95
Underreporting and misclassification of urinary tract cancer cases on death certificates. Epidemiology (1996) 0.92
Sociodemographic factors associated with nephrectomy in patients with metastatic renal cell carcinoma. J Urol (2009) 0.90
Impact of clinical variables on predicting disease-free survival of patients with surgically resected renal cell carcinoma. BJU Int (2008) 0.90
The value of histologic subtyping on outcomes of clear cell and papillary renal cell carcinomas: a meta-analysis. Urology (2010) 0.86
In search of a better crystal ball: recent advances in prognostic markers for clear-cell renal cell carcinoma. Expert Rev Anticancer Ther (2010) 0.84
Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood (2005) 8.37
Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev (2009) 8.08
Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature (2011) 6.57
von Hippel-Lindau disease. Lancet (2003) 6.20
Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst (2008) 6.00
HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell (2005) 5.47
Epidemiology and risk factors for kidney cancer. Nat Rev Urol (2010) 5.25
Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome. Cancer Cell (2002) 5.10
Biochemical diagnosis of pheochromocytoma: which test is best? JAMA (2002) 4.84
Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol (2013) 4.64
Post-analysis follow-up and validation of microarray experiments. Nat Genet (2002) 4.61
Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst (2002) 4.50
Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst (2005) 4.14
The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma. Cancer Cell (2002) 4.13
Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors. Clin Cancer Res (2008) 4.02
Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am (2002) 3.69
Mistaken identifiers: gene name errors can be introduced inadvertently when using Excel in bioinformatics. BMC Bioinformatics (2004) 3.65
Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling. Proc Natl Acad Sci U S A (2006) 3.51
Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. Blood (2011) 3.30
Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dubé syndrome. Am J Hum Genet (2005) 3.26
Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004. Br J Haematol (2008) 3.21
Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney. Cancer Res (2009) 3.17
Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer. J Clin Oncol (2004) 3.16
Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dubé syndrome. Cancer Epidemiol Biomarkers Prev (2002) 3.12
Robotic partial nephrectomy for complex renal tumors: surgical technique. Eur Urol (2007) 3.07
Renal tumors in the Birt-Hogg-Dubé syndrome. Am J Surg Pathol (2002) 3.06
Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol (2005) 3.01
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med (2015) 3.00
Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet (2003) 2.88
Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: An analysis of 26,758 cases. Int J Cancer (2006) 2.73
High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dubé-associated renal tumors. J Natl Cancer Inst (2005) 2.70
Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma. J Clin Oncol (2012) 2.61
Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst (2004) 2.60
Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome. Breast Cancer Res Treat (2005) 2.57
Correlation of magnetic resonance imaging tumor volume with histopathology. J Urol (2012) 2.55
Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev (2009) 2.50
Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid (2010) 2.48
US lung cancer trends by histologic type. Cancer (2014) 2.46
Trends in the incidence of testicular germ cell tumors in the United States. Cancer (2003) 2.45
11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation. J Nucl Med (2012) 2.42
Contemporary epidemiology of renal cell cancer. Cancer J (2008) 2.40
Evaluation of non-formalin tissue fixation for molecular profiling studies. Am J Pathol (2002) 2.38
Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst (2002) 2.38
Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance? Radiology (2013) 2.35
Evaluation and management of renal tumors in the Birt-Hogg-Dubé syndrome. J Urol (2005) 2.33
The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease. J Urol (2004) 2.32
Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2. Proc Natl Acad Sci U S A (2009) 2.28
Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen species. Mol Cell Biol (2009) 2.27
Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys. J Natl Cancer Inst (2008) 2.25
Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma. Clin Chem (2011) 2.24
Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines. J Natl Cancer Inst (2003) 2.19
Lung cysts, spontaneous pneumothorax, and genetic associations in 89 families with Birt-Hogg-Dubé syndrome. Am J Respir Crit Care Med (2007) 2.19
Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood (2009) 2.16
Racial disparities in incidence and outcome in multiple myeloma: a population-based study. Blood (2010) 2.12
The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels. Cancer Cell (2011) 2.12
D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging. J Urol (2011) 2.10
AIDS-related Burkitt lymphoma in the United States: what do age and CD4 lymphocyte patterns tell us about etiology and/or biology? Blood (2010) 2.10
International trends in the incidence of testicular cancer, 1973-2002. Cancer Epidemiol Biomarkers Prev (2010) 2.07
UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer. Cancer Genet Cytogenet (2010) 2.06
High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing. J Clin Endocrinol Metab (2006) 2.04
Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey. Prev Med (2004) 2.00
Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer. Cancer (2013) 1.97
Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management. J Clin Oncol (2013) 1.96
A geographic analysis of prostate cancer mortality in the United States, 1970-89. Int J Cancer (2002) 1.94
Molecular alterations in primary prostate cancer after androgen ablation therapy. Clin Cancer Res (2005) 1.88
Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer. J Urol (2007) 1.86
Lung cancer rates convergence in young men and women in the United States: analysis by birth cohort and histologic type. Int J Cancer (2003) 1.85
Rising prostate cancer rates in South Korea. Prostate (2006) 1.83
Identification and characterization of a novel folliculin-interacting protein FNIP2. Gene (2008) 1.82
Chronic kidney disease and risk of renal cell carcinoma: differences by race. Epidemiology (2015) 1.78
Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location. Hum Mutat (2004) 1.78
Gender is an age-specific effect modifier for papillary cancers of the thyroid gland. Cancer Epidemiol Biomarkers Prev (2009) 1.78
Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors. J Cell Biochem (2004) 1.76
Metabolism of kidney cancer: from the lab to clinical practice. Eur Urol (2012) 1.75
Cutaneous soft tissue sarcoma incidence patterns in the U.S. : an analysis of 12,114 cases. Cancer (2008) 1.74
Repeat partial nephrectomy on the solitary kidney: surgical, functional and oncological outcomes. J Urol (2010) 1.74
Percutaneous radio frequency ablation of small renal tumors: initial results. J Urol (2002) 1.74
Trends in the incidence of ocular melanoma in the United States, 1974-1998. Cancer Causes Control (2003) 1.72
An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies. Int J Cancer (2013) 1.71
Gene promoter methylation in prostate tumor-associated stromal cells. J Natl Cancer Inst (2006) 1.70
Consequences of adrenal venous sampling in primary hyperaldosteronism and predictors of unilateral adrenal disease. J Am Coll Surg (2010) 1.70
Sex disparities in cancer mortality and survival. Cancer Epidemiol Biomarkers Prev (2011) 1.68
Functional and oncologic outcomes of partial adrenalectomy for pheochromocytoma in patients with von Hippel-Lindau syndrome after at least 5 years of followup. J Urol (2010) 1.67
Expression of Birt-Hogg-Dubé gene mRNA in normal and neoplastic human tissues. Mod Pathol (2004) 1.67
Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs). Surgery (2007) 1.67
Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat (2004) 1.67
Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma. Cancer (2002) 1.65
Brain cancer incidence trends in relation to cellular telephone use in the United States. Neuro Oncol (2010) 1.63
Breast cancer trends among black and white women in the United States. J Clin Oncol (2005) 1.60
International patterns and trends in testis cancer incidence. Int J Cancer (2005) 1.60
Altered gene expression in phenotypically normal renal cells from carriers of tumor suppressor gene mutations. Cancer Biol Ther (2004) 1.58
Metastases to hemangioblastomas in von Hippel-Lindau disease. J Neurosurg (2006) 1.58
Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus. Cancer (2003) 1.57
Emerging and widening colorectal carcinoma disparities between Blacks and Whites in the United States (1975-2002). Cancer Epidemiol Biomarkers Prev (2006) 1.55
Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma. J Clin Oncol (2009) 1.55
Increasing incidence of testicular germ cell tumors among black men in the United States. J Clin Oncol (2005) 1.55